Feds Accuse Biotech Co., Execs Of 'Wide-Ranging Fraud'
Medical products maker Osiris Therapeutics Inc. and four top executives were accused of fraud by the U.S. Securities and Exchange Commission on Thursday, with the company settling for $1.5 million the...To view the full article, register now.
Already a subscriber? Click here to view full article